Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Sep-05-21 |
| | 10-Q | 10-K | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K |
| Revenues: |
| Product Sales | | | | | | | 24.7 | |
| Other | | | | | | | 2.2 | |
| In Vitro Diagnostics revenues | 27.4 | 27.6 | | 27.7 | 27.4 | 26.9 | 26.9 | |
| Revenue growth [+] | 1.9% | 2.5% | | 7.7% | 10.1% | 10.4% | 14.6% | |
| Product Sales | | | | | | | 8.8% | |
| EBITDA | 13.2 | 13.4 | | 14.0 | 14.0 | 14.1 | 14.2 | |
| EBITDA margin | 48.3% | 48.7% | | 50.5% | 51.0% | 52.4% | 52.7% | |
| Depreciation and amortization | 0.3 | 0.4 | | 0.3 | 0.4 | 0.4 | 0.4 | |
| EBIT | 12.9 | 13.1 | | 13.6 | 13.6 | 13.7 | 13.8 | |
| EBIT margin | 47.0% | 47.4% | | 49.3% | 49.6% | 51.0% | 51.2% | |
| |
| Revenue Mix | 26.9% | 27.6% | | 28.2% | 28.3% | 25.4% | 25.6% | |
|